State Street’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

State Street’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,829	Closed	-$25.3K	–	4836
2023 Q1	$25.3K	Hold	15,829	–	–	﹤0.01%	4648
2022 Q4	$31K	Hold	15,829	–	–	﹤0.01%	4664
2022 Q3	$55K	Hold	15,829	–	–	﹤0.01%	4638
2022 Q2	$54K	Sell	15,829 -186,307	-92%	-$1.03M	﹤0.01%	4711
2022 Q1	$1.84M	Buy	202,136 +9,158	+5%	+$139K	﹤0.01%	3599
2021 Q4	$4.15M	Buy	192,978 +39,801	+26%	+$1.06M	﹤0.01%	3333
2021 Q3	$5.01M	Buy	153,177 +9,214	+6%	+$337K	﹤0.01%	3239
2021 Q2	$6M	Buy	143,963 +103,976	+260%	+$5.33M	﹤0.01%	3159
2021 Q1	$2.62M	Buy	39,987 +5,042	+14%	+$352K	﹤0.01%	3326
2020 Q4	$2.3M	Sell	34,945 -369	-1%	-$24.1K	﹤0.01%	3311
2020 Q3	$1.92M	Sell	35,314 -1,536	-4%	-$118K	﹤0.01%	3214
2020 Q2	$3.52M	Buy	36,850 +377	+1%	+$28.1K	﹤0.01%	2938
2020 Q1	$1.87M	Sell	36,473 -2,837	-7%	-$297K	﹤0.01%	3091
2019 Q4	$3.23M	Buy	39,310 +2,696	+7%	+$189K	﹤0.01%	3053
2019 Q3	$3.13M	Buy	36,614 +729	+2%	+$77.8K	﹤0.01%	3026
2019 Q2	$4.58M	Buy	35,885 +58	+0.2%	+$8.35K	﹤0.01%	2873
2019 Q1	$6.46M	Buy	35,827 +1,135	+3%	+$164K	﹤0.01%	2640
2018 Q4	$3.85M	Sell	34,692 -860	-2%	-$112K	﹤0.01%	2841
2018 Q3	$4.8M	Buy	35,552 +589	+2%	+$81.2K	﹤0.01%	2887
2018 Q2	$4.82M	Sell	34,963 -823	-2%	-$113K	﹤0.01%	2874
2018 Q1	$4.93M	Sell	35,786 -927	-3%	-$126K	﹤0.01%	2802
2017 Q4	$4.51M	Buy	36,713 +298	+0.8%	+$40.9K	﹤0.01%	2835
2017 Q3	$4.97M	Sell	36,415 -1,038	-3%	-$157K	﹤0.01%	2806
2017 Q2	$6.58M	Buy	37,453 +3,540	+10%	+$504K	﹤0.01%	2600
2017 Q1	$4.07M	Buy	33,913 +687	+2%	+$71.5K	﹤0.01%	2808
2016 Q4	$3.24M	Buy	33,226 +853	+3%	+$78.2K	﹤0.01%	2901
2016 Q3	$3.04M	Buy	32,373 +236	+0.7%	+$23.7K	﹤0.01%	2810
2016 Q2	$3.46M	Buy	32,137 +440	+1%	+$51.5K	﹤0.01%	2820
2016 Q1	$3.8M	Sell	31,697 -1,407	-4%	-$148K	﹤0.01%	2697
2015 Q4	$3.94M	Buy	33,104 +174	+0.5%	+$22.4K	﹤0.01%	2667
2015 Q3	$5.61M	Buy	32,930 +553	+2%	+$106K	﹤0.01%	2464
2015 Q2	$6.27M	Buy	32,377 +208	+0.6%	+$38.6K	﹤0.01%	2515
2015 Q1	$4.77M	Buy	32,169 +1,605	+5%	+$244K	﹤0.01%	2584
2014 Q4	$4.77M	Sell	30,564 -87	-0.3%	-$12.5K	﹤0.01%	2592
2014 Q3	$4.39M	Sell	30,651 -769	-2%	-$111K	﹤0.01%	2616
2014 Q2	$4.1M	Sell	31,420 -649	-2%	-$82.4K	﹤0.01%	2701
2014 Q1	$3.92M	Buy	32,069 +588	+2%	+$63.7K	﹤0.01%	2714
2013 Q4	$3.35M	Sell	31,481 -3,839	-11%	-$373K	﹤0.01%	2806
2013 Q3	$3.96M	Sell	35,320 -2,838	-7%	-$322K	﹤0.01%	2659
2013 Q2	$4.3M	Buy	+38,158	New	+$4.67M	﹤0.01%	2551

Other funds holding SRGA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.3B AUM 18.84% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

State Street's SRGA Position: Q2 2023 in Review

State Street sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 15,829 shares — an estimated $25.3K sold.

State Street first reported a position in SRGA in Q2 2013 and held it in 40 quarters. The position peaked at $6.58M in Q2 2017. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

State Street reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
State Street sold 15,829 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $25.3K.
State Street first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
State Street's Surgalign Holdings, Inc. Common Stock position peaked at $6.58M in Q2 2017.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.